News/ Sales and Marketing Eleven seals deal with Roche on eye drug pipeline Andrew McConaghie Biotech, diabetic macular oedema, Eleven Therapeutics, licensing, Lucentis, Roche 0 Comment Deal helps biotech to move on from phase 3 failures Share X Eleven seals deal with Roche on eye drug pipeline https://pharmaphorum.com/news/eleven-seals-deal-roche-eye-drug-pipeline/